Dr. Vickery, an Atlanta native, is a pediatric allergist-immunologist. He serves as Chief of Allergy and Immunology and the Director of the Food Allergy Program at Children’s Healthcare of Atlanta and Associate Professor of Emory University School of Medicine.
Prior to joining Children’s, Dr. Vickery held faculty positions at Duke University School of Medicine and the University of North Carolina-Chapel Hill School of Medicine. While working at the University of North Carolina School of Medicine, he led a group that was first to show sustained unresponsiveness can occur after peanut OIT. He subsequently demonstrated that early treatment of peanut-allergic preschool children with OIT is safe and leads to better outcomes. Most recently at UNC, Dr. Vickery led the development of an investigational treatment for peanut allergy as a Senior Medical Director at Aimmune Therapeutics.
Dr. Vickery has published more than 50 papers in leading journals and has presented his work at national and international meetings. He has also contributed to the development of national food allergy treatment guidelines. Dr. Vickery has received several awards for clinical care as well as research awards from the American Academy of Allergy, Asthma and Immunology (AAAAI), the American College of Allergy, Asthma and Immunology, and the British Society of Allergy and Clinical Immunology.
Dr. Vickery’s research efforts focus on understanding the pathophysiology of food allergies and anaphylaxis as well as developing new therapies to treat them.
Focus of Practice
Areas of Interest
- Atopic dermatitis
- Eosinophilic disease
- Food allergies
- General pediatric allergy and immunology
Childrens Physician Group - Allergy and ImmunologyCenter for Advanced Pediatrics, 1400 Tullie Road NE Atlanta, GA 30329 Get Directions 404-785-5437
In the News
Promising Peanut Allergy Treatment Could Become Available in the Near Future
A new study found that gradually exposing children to peanut protein could increase their tolerance.
Experimental Treatment Helps 2 out of 3 Peanut Allergy Sufferers, Study Finds
Study results suggest that treatment can protect some children against accidental exposure to or ingestion of a very small amount of peanuts or peanut products.
New Peanut Allergy Drug Shows ‘Lifesaving’ Potential
Results from a new study may lead to approval of what could be the first drug that ameliorates potentially deadly reactions in children with severe peanut allergies.
New York Times